TRAPANI, DARIO
TRAPANI, DARIO
Dipartimento di Oncologia ed Emato-Oncologia
A conceptual framework for cautious escalation of anticancer treatment: How to optimize overall benefit and obviate the need for de-escalation trials
2024 I. Pourmir, H.K. Van Halteren, R. Elaidi, D. Trapani, F. Strasser, G. Vreugdenhil, M. Clarke
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024 C. Valenza, T.M. De Pas, A. Gaeta, G. Castellano, C. Santoro, A. Corona, G. Chiappini, G. Vivanet, D. Trapani, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Pennacchioli, G. Curigliano
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2024 L. Cantini, D. Trapani, L. Guidi, L. Boscolo Bielo, R. Scafetta, M. Koziej, L. Vidal, K.S. Saini, G. Curigliano
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024 S. Loibl, F. André, T. Bachelot, C.H. Barrios, J. Bergh, H.J. Burstein, M.J. Cardoso, L.A. Carey, S. Dawood, L. Del Mastro, C. Denkert, E.M. Fallenberg, P.A. Francis, H. Gamal-Eldin, K. Gelmon, C.E. Geyer, M. Gnant, V. Guarneri, S. Gupta, S.B. Kim, D. Krug, M. Kater, I. Meattini, M. Morrow, W. Janni, S. Paluch-Shimon, A. Partridge, P. Poortmans, L. Pusztai, M.M. Regan, J. Sparano, T. Spanic, S. Swain, S. Tjulandin, M. Toi, D. Trapani, A. Tutt, B. Xu, G. Curigliano, N. Harbeck
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all
2024 D. Trapani, P.J. Garcia, L. Schroeder, R. Abdul-Ghani, A. Hansali, P.N. Offutalu, W. Sewell, S. Shakoor, L. Yunfeng, N. Hashimoto, F.G. Moussy, A. Aceves Capri, K. Fleming
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
2024 S. Natangelo, D. Trapani, C. Koukoutzeli, L. Boscolo Bielo, G. Marvaso, B.A. Jereczek-Fossa, G. Curigliano
Biomarkers for antibody-drug conjugates in solid tumors
2024 J. Katrini, L. Boldrini, C. Santoro, C. Valenza, D. Trapani, G. Curigliano
Cardiotoxicity of Agents Used in Patients With Breast Cancer
2024 P. Zagami, D. Trapani, E. Nicolò, C. Corti, C. Valenza, C. Criscitiello, G. Curigliano, L.A. Carey
Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists
2024 T. Piggott, L. Moja, K. Jenei, T. Kredo, N. Skoetz, R. Banzi, D. Trapani, T. Leong, M. Mccaul, J.N. Lavis, E.A. Akl, F. Nonino, A. Iorio, J. Laurson-Doube, B.D. Huttner, H.J. Schünemann
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
2023 D. Trapani, E. Crimini, J. Sandoval, G. Curigliano
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives
2023 C. Valenza, G. Rizzo, M.I. Passalacqua, L. Boldrini, C. Corti, D. Trapani, G. Curigliano
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection
2023 D. Trapani, J. Sandoval, P.T. Aliaga, L. Ascione, P.P. Maria Berton Giachetti, G. Curigliano, O. Ginsburg
Impact of Prior Authorization on Patient Access to Cancer Care
2023 D. Trapani, L. Kraemer, H.S. Rugo, N.U. Lin
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
2023 P. Tarantino, G. Viale, M.F. Press, X. Hu, F. Penault-Llorca, A. Bardia, A. Batistatou, H.J. Burstein, L.A. Carey, J. Cortes, C. Denkert, V. Diéras, W. Jacot, A.K. Koutras, A. Lebeau, S. Loibl, S. Modi, M.F. Mosele, E. Provenzano, G. Pruneri, J.S. Reis-Filho, F. Rojo, R. Salgado, P. Schmid, S.J. Schnitt, S.M. Tolaney, D. Trapani, A. Vincent-Salomon, A.C. Wolff, G. Pentheroudakis, F. André, G. Curigliano
Common Sense Oncology: outcomes that matter
2023 C.M. Booth, M. Sengar, A. Goodman, B. Wilson, A. Aggarwal, S. Berry, D. Collingridge, A. Denburg, E.A. Eisenhauer, O. Ginsburg, D. Goldstein, S. Gunasekera, N. Hammad, K. Honda, C. Jackson, D. Karikios, K. Knopf, R. Koven, B.L. Marini, D. Maskens, F.Y. Moraes, G.R. Mohyuddin, B.S. Poudyal, C.S. Pramesh, F. Roitberg, F. Rubagumya, S. Schott, B. Sirohi, E. Soto-Perez-de-Celis, R. Sullivan, I.F. Tannock, D. Trapani, M. Tregear, W. van der Graaf, V. Vanderpuye, B. Gyawali
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
2023 E. Nicolò, P. Tarantino, O. D'Ecclesiis, G. Antonarelli, L. Boscolo Bielo, A. Marra, S. Gandini, E. Crimini, F. Giugliano, P. Zagami, C. Corti, D. Trapani, S. Morganti, C. Criscitiello, M. Locatelli, C. Belli, A. Esposito, I. Minchella, M. Cristofanilli, S.M. Tolaney, G. Curigliano
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
2023 K. Jenei, A.J.N. Raymakers, A. Bayle, K. Berger-Thürmel, A. Cherla, K. Honda, C.C.G.A. Jackson, D. Karikios, D. Trapani, S. Berry, B. Gyawali
Establishing a Lancet Oncology Commission on the humanitarian crisis of cancer
2023 G. Rodin, M. Skelton, N. Bhoo-Pathy, O. Dewachi, M. Li, D. Trapani, E. Smyth, M. Banegas, N. Salins, K. Unger-Saldaña, C. Zimmermann, R. Sullivan
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure
2023 G. Antonarelli, C. Corti, P. Tarantino, B.T. Salimbeni, P. Zagami, A. Marra, D. Trapani, S. Tolaney, J. Cortes, G. Curigliano
The immunogram of inflammatory breast cancer
2023 C. Valenza, D. Trapani, N. Fusco, X. Wang, M. Cristofanilli, N.T. Ueno, G. Curigliano